IFNAR1 and infection: Applying this analysis to highly susceptible C3HeB/FeJ mice, we found early anti-IFNAR treatment to increase the proportion of Ly6Glow lesions from 20 days after infection, with a more marked effect at the peak of disease at day 26 (Fig. 9, e and f).